Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colorectal Neoplasms, Hereditary Nonpolyposis × Naproxen × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pleural Effusion, Malignant 1 Pleural Effusion 1 Lung Neoplasms 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Mesalamine 2 Colonoscopy 2 Specimen Handling 1 Omacor 1 Nivolumab 1 Naproxen 1 Biopsy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05411718 2025-11-13

A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

M.D. Anderson Cancer Center

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡